You are here

Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly asks to join GLP-1 compounding lawsuit

BioSpace

Fri, 01/3/25 - 10:47 am

Tags:

Eli Lilly, FDA, legal, compounded drugs, GLP-1 agonist

Use of diabetes and anti-obesity drugs surges nationwide

Axios

Fri, 01/3/25 - 10:07 am

Tags:

obesity, diabetes, Eli Lilly, Novo Nordisk, Ozempic, Wegovy, Mounjaro, Zepbound, GLP-1 agonist

10 clinical trials to watch in the first half of 2025

BioPharma Dive

Thu, 01/2/25 - 11:42 am

Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver

Forbes

Wed, 01/1/25 - 10:49 pm

Tags:

Eli Lilly, Zepbound, insurance

Zepbound, Mounjaro shortages are resolved, FDA confirms

BioPharma Dive

Thu, 12/19/24 - 09:36 pm

Tags:

FDA, Eli Lilly, Zepbound, Mounjaro, drug shortages

Big Pharma’s new DTC play: partnering with digital health providers

Pharma Voice

Wed, 12/18/24 - 11:17 am

Tags:

digital health, Big Pharma, DTC, Ro, LillyDirect, telehealth, Eli Lilly

A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss

Pharmaphorum

Wed, 12/18/24 - 11:14 am

Tags:

patients, GLP-1 agonists, obesity, weight loss, Novo Nordisk, Eli Lilly

UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy

Yahoo/Reuters

Fri, 12/13/24 - 11:43 am

Tags:

Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, UK, obesity

Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025

Motley Fool

Thu, 12/12/24 - 11:41 pm

Tags:

Eli Lilly, orforglipron

Eli Lilly is going to test Zepbound as a treatment for addiction

Quartz

Wed, 12/11/24 - 10:44 pm

Tags:

Eli Lilly, David Ricks, Zepbound, addiction, alcohol-use disorder

Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro

Yahoo Finance

Wed, 12/11/24 - 11:01 am

Tags:

Eli Lilly, Ro, telehealth, Zepbound

Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump

MSN/Reuters

Tue, 12/10/24 - 09:58 pm

Tags:

Eli Lilly, David Ricks, Pharma CEOs, Donald Trump, taxes, regulatory

ASH: Eli Lilly touts novel BTK trial win for Jaypirca as execs defend survival data blemish

Fierce Pharma

Tue, 12/10/24 - 11:10 am

Tags:

ASH 2024, Eli Lilly, Jaypirca, CLL

Trump, RFK Jr. dine with Pfizer and Lilly execs

Axios

Sun, 12/8/24 - 09:55 pm

Tags:

Donald Trump, Pfizer, Eli Lilly, PhRMA, Robert F Kennedy Jr., cancer

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin

Fierce Pharma

Thu, 12/5/24 - 04:19 pm

Tags:

Eli Lilly, Wisconsin, drug manufacturing

For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access

Fierce Pharma

Wed, 12/4/24 - 11:05 pm

Tags:

Eli Lilly, Mounjaro, obesity, England

Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial

BioPharma Dive

Wed, 12/4/24 - 11:02 am

Tags:

Eli Lilly, Zepbound, Novo Nordisk, Wegovy, clinical trials, weight loss, obesity

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Pharma Live

Tue, 12/3/24 - 11:36 am

Tags:

Novo Nordisk, India, Wegovy, Eli Lilly, Zepbound

Four oral GLP-1R products in Phase III trials as race intensifies

Clinical Trials Arena

Tue, 12/3/24 - 11:17 am

Tags:

Novo Nordisk, Eli Lilly, Jiangsu Hengrui, GLP-1R, GLP-1 agonists, clinical trials

Why Amgen's Weight Loss Result Is a Win for Eli Lilly

Motley Fool

Wed, 11/27/24 - 11:30 am

Tags:

Amgen, MariTide, Eli Lilly, Zepbound

Pages

last 30 twitter posts